TY - JOUR
T1 - Resistance exercise versus aerobic exercise combined with metformin therapy in the treatment of type 2 diabetes
T2 - A 12-week comparative clinical study
AU - Abdelbasset, Walid Kamal
N1 - Publisher Copyright:
© 2021 Bentham Science Publishers.
PY - 2021/8
Y1 - 2021/8
N2 - Background: Both exercise and metformin are used to control blood glucose levels in patients with type 2 diabetes mellitus (T2DM), while no previous studies have investigated the effect of resistance exercise combined with metformin versus aerobic exercise with metformin in T2DM patients. Objectives: This study was conducted to compare the effects of resistance exercise combined with metformin versus aerobic exercise with metformin in T2DM patients. Methods: A total of fifty-seven T2DM patients with a mean age of 46.2±8.3 years were randomized to three study groups; each group included nineteen patients. The first group conducted a resistance exercise program (REP, 50-60% of 1RM, for 40-50 min) combined with metformin, the second group conducted an aerobic exercise program (AEP, 50-70% maxHR, for 40-50 min) combined with metformin, and the third group received only metformin without exercise intervention (Met group). The study program was conducted thrice weekly for consecutive twelve weeks. Fast-ing blood glucose (FBG), glycated hemoglobin (HbA1c), homeostatic model assessment of insulin resistance (HOMA-IR), and maximal oxygen uptake (VO2 max) were evaluated before and after study intervention. Results: Significant differences were reported after the 12-week intervention inter-groups in the outcome variables (p˂0.05). FBG, HbA1c, HOMA-IR, and VO2 max improved significantly in the REP group (p˂0.001) and also in the AEP group (p=0.016, p=0.036, p=0.024, and p=0.019 respec-tively) while the Met group showed an only significant reduction in FBG (p=0.049), and non-signif-icant changes in HbA1c, HOMA-IR, and VO2 max (p˃0.05). REP group achieved greater improve-ments than AEP group (FBG, p=0.034; HbA1c%, p=0.002; HOMA-IR, p˂0.001; and VO2 max, p=0.024). Conclusion: Both resistance and aerobic exercise programs combined with metformin are effective in controlling T2DM. Resistance exercise combined with metformin is more effective than aerobic exercise combined with metformin in the treatment of T2DM. Trial Registration: This study is retrospectively registered in www.clinicaltrials.gov (ID: NC-T05004948).
AB - Background: Both exercise and metformin are used to control blood glucose levels in patients with type 2 diabetes mellitus (T2DM), while no previous studies have investigated the effect of resistance exercise combined with metformin versus aerobic exercise with metformin in T2DM patients. Objectives: This study was conducted to compare the effects of resistance exercise combined with metformin versus aerobic exercise with metformin in T2DM patients. Methods: A total of fifty-seven T2DM patients with a mean age of 46.2±8.3 years were randomized to three study groups; each group included nineteen patients. The first group conducted a resistance exercise program (REP, 50-60% of 1RM, for 40-50 min) combined with metformin, the second group conducted an aerobic exercise program (AEP, 50-70% maxHR, for 40-50 min) combined with metformin, and the third group received only metformin without exercise intervention (Met group). The study program was conducted thrice weekly for consecutive twelve weeks. Fast-ing blood glucose (FBG), glycated hemoglobin (HbA1c), homeostatic model assessment of insulin resistance (HOMA-IR), and maximal oxygen uptake (VO2 max) were evaluated before and after study intervention. Results: Significant differences were reported after the 12-week intervention inter-groups in the outcome variables (p˂0.05). FBG, HbA1c, HOMA-IR, and VO2 max improved significantly in the REP group (p˂0.001) and also in the AEP group (p=0.016, p=0.036, p=0.024, and p=0.019 respec-tively) while the Met group showed an only significant reduction in FBG (p=0.049), and non-signif-icant changes in HbA1c, HOMA-IR, and VO2 max (p˃0.05). REP group achieved greater improve-ments than AEP group (FBG, p=0.034; HbA1c%, p=0.002; HOMA-IR, p˂0.001; and VO2 max, p=0.024). Conclusion: Both resistance and aerobic exercise programs combined with metformin are effective in controlling T2DM. Resistance exercise combined with metformin is more effective than aerobic exercise combined with metformin in the treatment of T2DM. Trial Registration: This study is retrospectively registered in www.clinicaltrials.gov (ID: NC-T05004948).
KW - Aerobic exercise
KW - Glucose oxidation
KW - Insulin resistance
KW - Maximal oxygen uptake
KW - Metformin
KW - Resistance exercise
KW - Type 2 diabetes mellitus
UR - http://www.scopus.com/inward/record.url?scp=85116919307&partnerID=8YFLogxK
U2 - 10.2174/1871530320999200918143227
DO - 10.2174/1871530320999200918143227
M3 - Article
C2 - 32957900
AN - SCOPUS:85116919307
SN - 1871-5303
VL - 21
SP - 1531
EP - 1536
JO - Endocrine, Metabolic and Immune Disorders - Drug Targets
JF - Endocrine, Metabolic and Immune Disorders - Drug Targets
IS - 8
ER -